News

Ending the Impasse on Drug Pricing

More interaction between R&D and payers will be essential if innovative therapies are to become more accessible for patients, and more profitable for manufacturers, said panelists at the 2018 Galien Foundation Forum.
/ read more /

NIBRT, Valitacell Aim to Validate New Analytical Technology

The partnership, co-funded by Enterprise Ireland, will develop technologies for monitoring the quality of biopharma processes.
/ read more /

QPS Expands US-Based Phase I Clinical Trial Capabilities

The contract research organization has increased its US-based early phase clinical capacity and doubled its specialty lab space.
/ read more /

IRBM Strengthens Position in Neurodegenerative Disease Research Through Extended Collaboration

IRBM has extended its collaboration with CHDI Foundation to progress the development of therapeutics for Huntington's disease.
/ read more /

Survey Predicts Drug Product Formulation Recognition and Increasing Budgets

Formulation issues cause significant drug project delays and project failures, according to a 2018 survey conducted by Informa Pharma Intelligence, Rentschler Biopharma, and LEUKOCARE.
/ read more /

Opioid Overdose Reversal Products are Chemically Stable Well Past Expiration Date

Researchers evaluated the chemical stability of two different naloxone products administered to prevent opioid overdose deaths and found the products to have a significantly extended shelf life than previously known.
/ read more /

New Technology

High-Throughput Microplate Reader Cuts Down Screening Time

A new, high-throughput microplate reader cuts down on screening time and works faster than standard ultra-high-performance liquid chromatography processes.
/ read more /

Microdialysis Technology Updates Data Access for Oncology Drug Development

Charles River Laboratories has announced a data expansion in its compendium of tumor models for oncology drug R&D.
/ read more /